Cargando…
Pronounced reversible hyperammonemic encephalopathy associated with combined valproate–topiramate therapy in a 7-year-old girl
Valproate is one of the most frequently used anticonvulsive drugs in children and adults. Valproate is a generally well tolerated medication. However, encephalopathy with or without hyperammonemia is one of its rare adverse events. We present a 7-year-old girl who suffered from epilepsy with general...
Autores principales: | Weise, Sebastian, Syrbe, Steffen, Preuss, Matthias, Bertsche, Astrid, Merkenschlager, Andreas, Bernhard, Matthias K |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4469596/ https://www.ncbi.nlm.nih.gov/pubmed/26090323 http://dx.doi.org/10.1186/s40064-015-1057-9 |
Ejemplares similares
-
Valproate-induced hyperammonemic encephalopathy enhanced by topiramate and phenobarbitone: A case report and an update
por: Vivekanandan, S., et al.
Publicado: (2010) -
Non-Hyperammonemic valproate encephalopathy
por: Farooq, Omar, et al.
Publicado: (2014) -
Valproate-Induced Hyperammonemic Encephalopathy
por: Farooq, Faiza, et al.
Publicado: (2017) -
A Case of Valproate Induced Hyperammonemic Encephalopathy
por: Tarafdar, Surjit, et al.
Publicado: (2011) -
Valproate induced hyperammonemic encephalopathy treated by haemodialysis
por: Chauhan, Vinay Singh, et al.
Publicado: (2017)